March 31, 2017 / 4:23 PM / 8 months ago

BRIEF-US Patent board rules for Biogen in Forward patent case

March 31 (Reuters) - Forward Pharma A/S

* US Patent Trial and Appeal Board ruling is about “interference” and follows earlier ruling for biogen on ipr Further company coverage: (Reporting By Caroline Humer)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below